This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schabath, M. B. Articles by Wu, X. Search for Related Content PubMed PubMed Citation Articles by Schabath, M. B. Articles by Wu, X.

Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk

Departments of ¹ Epidemiology and ² Urology, University of Texas M.D. Anderson Cancer Center; ³ University of Texas Houston School of Public Health; and ⁴ Scott Department of Urology, Baylor College of Medicine and Methodist Hospital, Houston, Texas

Requests for reprints: Xifeng Wu, Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Unit 189, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-745-2485; Fax: 713-792-0807. E-mail: xwu{at}mdanderson.org

Introduction: The nucleotide excision repair gene, xeroderma pigmentosum complementation group D (XPD), has been hypothesized to have a role in cancer risk, but results from prior molecular epidemiologic studies and genotype-phenotype analyses are conflicting.

Materials and Methods: We examined the frequency of the XPD Asp312Asn polymorphism in exon 10 and the XPD Lys751Gln polymorphism in exon 23 in 505 incident bladder cancer cases and 486 healthy controls.

Results: Overall, the XPD exon 10 and 23 genotypes were not associated with bladder cancer risk, after adjusting for age, sex, ethnicity, and smoking status. A gender-specific role was evident that showed an increased risk for women, but not for men, associated with the variant genotypes for both exons. For example, when the exon 23 variant allele genotypes were combined (Lys/Gln + Gln/Gln), there was an increased bladder cancer risk in women [odds ratio (OR), 1.69; 95% confidence interval (95% CI), 1.12-2.58] but not in men (OR, 0.99; 95% CI, 0.79-1.24; P_interaction = 0.041; OR, 1.62; 95% CI, 1.02-2.58). There was also a gene-smoking interaction that showed the variant alleles for either exon or the combination of both increase the risk of bladder cancer for light and heavy smokers. For exon 23 (P_interaction = 0.057; OR, 1.21; 95% CI, 0.99-1.47), heavy smokers (20 pack-years) who carried the exon 23 variant allele genotypes had an OR of 4.13 (95% CI, 2.53-6.73), whereas heavy smokers with the wild-type genotypes were at lower risk (OR, 3.55; 95% CI, 2.19-5.75). Moderate smokers (1-19 pack-years) with the variant allele genotypes had an OR of 1.54 (95% CI, 0.94-2.53), whereas moderate smokers with the wild-type genotypes had an OR of 1.12 (95% CI, 0.63-1.98).

Conclusions: Although we did not observe main effects associated with the XPD genotypes, these results do suggest the variant allele genotypes were associated with increased bladder cancer risk in women and smokers with statistically significant interactions in the exon 23 polymorphism. Although there is biological plausibility, these novel findings for gender and smoking should be interpreted with caution upon confirmation in larger studies.

This article has been cited by other articles:

				S. Michiels, A. Laplanche, T. Boulet, P. Dessen, B. Guillonneau, A. Mejean, F. Desgrandchamps, M. Lathrop, A. Sarasin, and S. Benhamou Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk Carcinogenesis, May 1, 2009; 30(5): 763 - 768. [Abstract] [Full Text] [PDF]

				G. Capella, G. Pera, N. Sala, A. Agudo, F. Rico, G. Del Giudicce, M. Plebani, D. Palli, H. Boeing, H B. Bueno-de-Mesquita, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study Int. J. Epidemiol., December 1, 2008; 37(6): 1316 - 1325. [Abstract] [Full Text] [PDF]

				J. Lin, X. Pu, W. Wang, S. Matin, N. M. Tannir, C. G. Wood, and X. Wu Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma Carcinogenesis, November 1, 2008; 29(11): 2112 - 2119. [Abstract] [Full Text] [PDF]

				F. Wang, D. Chang, F.-l. Hu, H. Sui, B. Han, D.-d. li, and Y.-s. Zhao DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 507 - 517. [Abstract] [Full Text] [PDF]

				L. Qiu, S. Leng, Z. Wang, Y. Dai, Y. Zheng, and Z. Wang Path Analysis of Biomarkers of Exposure and Early Biological Effects among Coke-Oven Workers Exposed to Polycyclic Aromatic Hydrocarbons Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1193 - 1199. [Abstract] [Full Text] [PDF]

				Y. Zhu, M. Lai, H. Yang, J. Lin, M. Huang, H.B. Grossman, C. P. Dinney, and X. Wu Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer Carcinogenesis, March 1, 2007; 28(3): 698 - 703. [Abstract] [Full Text] [PDF]

				A. S. Andrew, H. H. Nelson, K. T. Kelsey, J. H. Moore, A. C. Meng, D. P. Casella, T. D. Tosteson, A. R. Schned, and M. R. Karagas Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility Carcinogenesis, May 1, 2006; 27(5): 1030 - 1037. [Abstract] [Full Text] [PDF]

				M. Garcia-Closas, N. Malats, F. X. Real, R. Welch, M. Kogevinas, N. Chatterjee, R. Pfeiffer, D. Silverman, M. Dosemeci, A. Tardon, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 536 - 542. [Abstract] [Full Text] [PDF]